definiens: herein means [ * * * ] ; and for the avoidance of doubt, Company agrees that thi s Section 10.4(a ) shall not be interpreted so as to prohibit the owners of mRNA RiboTherapeutics and/or [COMPANY] from [ * * * ] ; ( c ) the purchaser of mRNA RiboTherapeutics or Ce llscript, respectively, will pay [ * * * ] ; 23 ( d ) on the effective date of any such sale of [ * * * ], the purchased company ( whether mRNA RiboTherapeutics or [COMPANY] ) and the purchaser a nd their assignees and successors in ownership ther eof shall [ * * * ] : ( i ) grant [ * * * ] Sublicenses to affiliates and Third Par ties [ * * * ], and ( ii ) grant [ * * * ] Sublicenses to affiliates and any Third Parties to research, develop, manufacture and /or commercialize any number of products [ * * * ] without being subject to any of the restrictions, limitations or requirements that the sublicensee is [ * * * ] as is required of the Primary Sublicensors i n Section 10.3 ; and ( d ) on the effective date of any such sale of mo re than fifty percent ( 50 % ) of the outstanding stoc k or ownership interest or all of the business or assets of mRNA RiboTherapeutics or [COMPANY] [ * * * ], all of the rights of the Primary Sublicensors to grant Product Sublic enses pursuant to Section 10.3 shall remain only wi th the Primary Sublicensors for which their stock, ownersh ip interest, business and assets were not sold